Last reviewed · How we verify

NCT05247242

Physical Activity and Social Engagement for Persons With Disabilities in an Underserved Community

Completed NA Last updated 20 January 2025
What this trial tests

NA trial testing Lakeshore Online Fitness (Online) in Disability Physical in 10 participants. Completed in 27 December 2023.

Timeline
19 July 2022
Primary endpoint
27 December 2023
27 December 2023

Quick facts

Lead sponsorUniversity of Alabama at Birmingham
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeother
Enrollment10
Start date19 July 2022
Primary completion27 December 2023
Estimated completion27 December 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Alabama at Birmingham

Who can join

18 and older, any sex, with Disability Physical or Chronic Conditions, Multiple. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using a community-based participatory approach, this project aims to evaluate the feasibility, acceptability, and preliminary efficacy of two technology-driven group activity programs on socioemotional health and physical activity in a local underserved community, Tarrant, Alabama. Participants will complete two six-week programs, specifically Lakeshore Online Fitness (Online) and Get Active with Virtual Reality (VR).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Disability Physical

Currently open trials in the same condition.

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05247242.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing